Form D Explorer

Inspect source fieldsReport a record issue

Form D — Prolifagen, Inc.

0002086999-25-000001 · filed Sep 23, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
—
Reported amount sold
$3,026,864
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Prolifagen, Inc.
CIK
2086999
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2025
Address
3805 OLD EASTON ROAD
DOYLESTOWN, Pennsylvania 18902
Phone
610-656-5229

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗